Tölle, Malte https://orcid.org/0000-0002-0804-5794
Burger, Lukas https://orcid.org/0000-0003-4480-6076
Kelm, Halvar https://orcid.org/0000-0002-5125-4516
André, Florian
Bannas, Peter https://orcid.org/0000-0002-7102-534X
Diller, Gerhard https://orcid.org/0000-0003-3050-5248
Frey, Norbert https://orcid.org/0000-0001-7611-378X
Garthe, Philipp
Groß, Stefan https://orcid.org/0000-0003-4121-7161
Hennemuth, Anja https://orcid.org/0000-0002-0737-7375
Kaderali, Lars https://orcid.org/0000-0002-2359-2294
Krüger, Nina https://orcid.org/0000-0002-2688-9480
Leha, Andreas
Martin, Simon https://orcid.org/0000-0003-3347-4520
Meyer, Alexander https://orcid.org/0000-0002-6944-2478
Nagel, Eike https://orcid.org/0000-0002-6044-950X
Orwat, Stefan https://orcid.org/0000-0002-2836-6333
Scherer, Clemens https://orcid.org/0000-0003-2816-6793
Seiffert, Moritz https://orcid.org/0000-0002-3940-9079
Seliger, Jan Moritz
Simm, Stefan https://orcid.org/0000-0001-9371-2709
Friede, Tim https://orcid.org/0000-0001-5347-7441
Seidler, Tim https://orcid.org/0000-0002-6158-5087
Engelhardt, Sandy https://orcid.org/0000-0001-8816-7654
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung
Klaus Tschira Stiftung
Bundesministerium für Bildung und Forschung (01KD2215D)
Carl-Zeiss-Stiftung (P2022-08-01)
Article History
Received: 18 April 2024
Accepted: 14 January 2025
First Online: 3 February 2025
Declarations
:
: Sandy Engelhardt reports speaker honoraria from Boehringer Ingelheim. Norbert Frey reports speaker honoraria, presentations or advisory board consultations from AstraZeneca, Bayer AG, Boehringer Ingelheim, Novartis, Pfizer, Daiichi Sankyo Deutschland. Tim Seidler reports research, educational, or travel grants and honoraria for lectures or advisory board consultations from Abbott Vascular, AstraZeneca, BoehringerIngelheim, Bristol Myers Squibb, Corvia, Cytokinetics, Edwards Life Sciences, Medtronic, Myocardia, Novartis, Pfizer, Teleflex. Alexander Meyer reports consulting or lecturing fees from Medtronic, Bayer, Pfizer. Clemens Scherer reports speaker honorarium from AstraZeneca. None are related to the content of the manuscript. The other authors declare no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. Ethical approval was waived by the local Ethics Committees of Heidelberg (S-475/2021), Göttingen (11/6/21), Hamburg (2021-200262-BO-bet), Munich (21-0497), Münster (2021-487-b-S), Greifswald (BB 091/24), and Frankfurt (2021-366_1) in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. In Berlin, a multi-centric study must not explicitly be confirmed when another institutional ethics board waived approval.
: Informed consent was not obtained due to the retrospective nature of the study.